SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-324523
Filing Date
2020-12-22
Accepted
2020-12-22 16:05:53
Documents
8
Period of Report
2020-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d73975d8k.htm 8-K 22525
2 EX-10.1 d73975dex101.htm EX-10.1 633647
3 GRAPHIC g73975g1221184451560.jpg GRAPHIC 33682
4 GRAPHIC g73975g1221184451887.jpg GRAPHIC 31019
5 GRAPHIC g73975g1221184452277.jpg GRAPHIC 50574
6 GRAPHIC g73975g1221184456287.jpg GRAPHIC 32319
7 GRAPHIC g73975g1221184456645.jpg GRAPHIC 52213
8 GRAPHIC g73975g1221184457098.jpg GRAPHIC 38669
  Complete submission text file 0001193125-20-324523.txt   986858
Mailing Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39402 | Film No.: 201408025
SIC: 2834 Pharmaceutical Preparations